Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 10, 2006, Pages 719-725

  Hedenmalm, Karin ^a,b   Sundström, Anders ^b   Spigset, Olav ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adverse reaction; Alopecia; Selective serotonin reuptake inhibitors; Spontaneous reporting systems

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; AMILORIDE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DEXTROPROPOXYPHENE; DIAZEPAM; DIGOXIN; DILTIAZEM; ESCITALOPRAM; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FLUNITRAZEPAM; FLUOXETINE; FLUVOXAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; LORATADINE; METOPROLOL; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; OXAZEPAM; PAROXETINE; POTASSIUM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SOTALOL; UNINDEXED DRUG; WARFARIN; ZOLPIDEM;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIARRHEA; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; DRY SKIN; ECZEMA; FEMALE; HAIR LOSS; HIRSUTISM; HUMAN; MALE; NAIL DISEASE; PHARMACY; PRIORITY JOURNAL; RETINA MACULA EDEMA; SEX DIFFERENCE; SKIN DISEASE; STATISTICAL SIGNIFICANCE; SWEDEN; URINE RETENTION; WEIGHT REDUCTION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ALOPECIA; BAYES THEOREM; CITALOPRAM; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SWEDEN; WORLD HEALTH ORGANIZATION;

EID: 33750452683     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1270     Document Type: Article

References (18)

1. Mercke Y, Sheng H, Khan T, et al. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12: 35-42.
2. Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother 1999; 33: 631-637.
3. Bate A, Lindquist M, Edwards M et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-321.
4. Orre R, Lansner A, Bate A, et al. Bayesian neural networks with confidence estimations applied to data mining. Computational Statistics and Data Analysis 2000; 34: 473-493.
5. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002; 27: 389-405.
6. Gulec AT, Tanriverdi N, Duru C, et al. The role of psychological factors in alopecia areata, and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-356.
7. Slominski A, Wortsman J, Tobin DJ. The cutaneous serotoninergic/ melatoninergic system: securing a place under the sun. FASEB J 2005; 19: 176-194.
8. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ, et al. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata. Int J Dermatol 1999; 38: 798-799.
9. Huang J, Gong Q, Li G, et al. Serotonin in alopecia areata: an enzyme immunoassay study. Int J Dermatol 2004; 43: 78-80.
10. Bhatara VS, Gupta S, Freeman JW. Fluoxetine associated paresthesias and alopecia in a woman who tolerated sertraline. J Clin Psychiatry 1996; 57: 227.
11. Seifritz E, Hatzinger M, Muller MJ, et al. Hair loss associated with fluoxetine, but not with citalopram. Can J Psychiatry 1995; 40: 362.
12. Zalsman G, Sever J, Munitz H. Hair loss associated with paroxetine treatment: a case report. Clin Neuropharmacol 1999; 22: 246-247.
13. Ogilvie AD. Hair loss during fluoxetine treatment. Lancet 1993; 342: 1423.
14. Bourgeois JA. Two cases of hair loss after sertraline, use. J Clin Psychopharmacol 1996; 16: 91-92.
15. Gupta S, Major LF. Hair loss associated with fluoxetine. Br J Psychiatry 1991; 159: 737-738.
16. Mareth TR. Hair loss associated with fluoxetine use in two family members. J Clin Psychiatry 1994; 55:163.
17. Jenike MA. Severe hair loss associated with fluoxetine use. Am J Psychiatry 1991; 148: 392.
18. Parameshwar E, Hair loss associated with fluvoxamine use. Am J Psychiatry 1996; 153: 581-582.